Home › Abdominal Aortic Aneurysm › NCT06586021
Evaluation of the Aortoseal™ for Sealing and Fixation of AAA Endovascular Grafts to Aortic Wall
Recruiting
SEAL - Safety & Feasibility Evaluation of the Aortoseal™ for Seal and Fixation of Abdominal Aortic Aneurysms (AAA) Endovascular Grafts to the Aortic Wall"
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Subjects diagnosed with a qualifying AAA suitable for elective endovascular repair with Endovascular Graft System or have a previously placed endovascular graft.
About the study
The Aortoseal Endostapling System is indicated in patients undergoing, or having undergone, treatment of an abdominal aortic aneurysm (AAA) with an endovascular graft to provide enhanced fixation and apposition to the aorta.
What is being tested
- Aortoseal Endostapling System (device)
Sponsor: Endoron Medical · Participants: 25 · Started: Feb 6, 2024
Contact the study team
Official record on ClinicalTrials.gov — NCT06586021
Locations in the U.S.
| Virginia | Sentara Health Research Center, Norfolk |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.